nodes	percent_of_prediction	percent_of_DWPC	metapath
Phendimetrazine—Abdominal pain—Exemestane—breast cancer	0.00309	0.00461	CcSEcCtD
Phendimetrazine—Diarrhoea—Fulvestrant—breast cancer	0.00308	0.00459	CcSEcCtD
Phendimetrazine—Headache—Lapatinib—breast cancer	0.00306	0.00457	CcSEcCtD
Phendimetrazine—Tremor—Chlorambucil—breast cancer	0.00306	0.00457	CcSEcCtD
Phendimetrazine—Flushing—Melphalan—breast cancer	0.00304	0.00453	CcSEcCtD
Phendimetrazine—Decreased appetite—Letrozole—breast cancer	0.00302	0.0045	CcSEcCtD
Phendimetrazine—Decreased appetite—Anastrozole—breast cancer	0.00302	0.0045	CcSEcCtD
Phendimetrazine—Agitation—Chlorambucil—breast cancer	0.003	0.00448	CcSEcCtD
Phendimetrazine—Insomnia—Raloxifene—breast cancer	0.00298	0.00445	CcSEcCtD
Phendimetrazine—Dizziness—Fulvestrant—breast cancer	0.00297	0.00444	CcSEcCtD
Phendimetrazine—Constipation—Anastrozole—breast cancer	0.00297	0.00443	CcSEcCtD
Phendimetrazine—Constipation—Letrozole—breast cancer	0.00297	0.00443	CcSEcCtD
Phendimetrazine—Dizziness—Toremifene—breast cancer	0.00293	0.00438	CcSEcCtD
Phendimetrazine—Abdominal pain—Ixabepilone—breast cancer	0.00291	0.00435	CcSEcCtD
Phendimetrazine—Nausea—Lapatinib—breast cancer	0.0029	0.00433	CcSEcCtD
Phendimetrazine—Decreased appetite—Idarubicin—breast cancer	0.00286	0.00427	CcSEcCtD
Phendimetrazine—Headache—Fulvestrant—breast cancer	0.00282	0.0042	CcSEcCtD
Phendimetrazine—Headache—Toremifene—breast cancer	0.00278	0.00415	CcSEcCtD
Phendimetrazine—Abdominal pain—Anastrozole—breast cancer	0.00274	0.00409	CcSEcCtD
Phendimetrazine—Abdominal pain—Letrozole—breast cancer	0.00274	0.00409	CcSEcCtD
Phendimetrazine—Diarrhoea—Exemestane—breast cancer	0.00267	0.00399	CcSEcCtD
Phendimetrazine—Nausea—Fulvestrant—breast cancer	0.00267	0.00399	CcSEcCtD
Phendimetrazine—Flushing—Vinorelbine—breast cancer	0.00265	0.00396	CcSEcCtD
Phendimetrazine—Nausea—Toremifene—breast cancer	0.00264	0.00393	CcSEcCtD
Phendimetrazine—Vision blurred—Goserelin—breast cancer	0.00262	0.00391	CcSEcCtD
Phendimetrazine—Abdominal pain—Raloxifene—breast cancer	0.0026	0.00389	CcSEcCtD
Phendimetrazine—Abdominal pain—Idarubicin—breast cancer	0.0026	0.00389	CcSEcCtD
Phendimetrazine—Dizziness—Exemestane—breast cancer	0.00258	0.00385	CcSEcCtD
Phendimetrazine—Anorexia—Chlorambucil—breast cancer	0.00254	0.0038	CcSEcCtD
Phendimetrazine—Abdominal pain upper—Paclitaxel—breast cancer	0.00254	0.00379	CcSEcCtD
Phendimetrazine—Diarrhoea—Ixabepilone—breast cancer	0.00252	0.00376	CcSEcCtD
Phendimetrazine—Sweating—Irinotecan—breast cancer	0.00252	0.00376	CcSEcCtD
Phendimetrazine—Sweating—Mitoxantrone—breast cancer	0.00252	0.00376	CcSEcCtD
Phendimetrazine—Palpitations—Goserelin—breast cancer	0.00246	0.00367	CcSEcCtD
Phendimetrazine—Sweating—Gemcitabine—breast cancer	0.00245	0.00366	CcSEcCtD
Phendimetrazine—Headache—Exemestane—breast cancer	0.00245	0.00365	CcSEcCtD
Phendimetrazine—Dizziness—Ixabepilone—breast cancer	0.00244	0.00364	CcSEcCtD
Phendimetrazine—Diarrhoea—Anastrozole—breast cancer	0.00237	0.00354	CcSEcCtD
Phendimetrazine—Diarrhoea—Letrozole—breast cancer	0.00237	0.00354	CcSEcCtD
Phendimetrazine—Anorexia—Vinblastine—breast cancer	0.00233	0.00348	CcSEcCtD
Phendimetrazine—Nausea—Exemestane—breast cancer	0.00232	0.00346	CcSEcCtD
Phendimetrazine—Decreased appetite—Chlorambucil—breast cancer	0.00232	0.00346	CcSEcCtD
Phendimetrazine—Headache—Ixabepilone—breast cancer	0.00231	0.00345	CcSEcCtD
Phendimetrazine—Hyperhidrosis—Tamoxifen—breast cancer	0.0023	0.00343	CcSEcCtD
Phendimetrazine—Dizziness—Letrozole—breast cancer	0.00229	0.00343	CcSEcCtD
Phendimetrazine—Dizziness—Anastrozole—breast cancer	0.00229	0.00343	CcSEcCtD
Phendimetrazine—Tachycardia—Melphalan—breast cancer	0.00227	0.00339	CcSEcCtD
Phendimetrazine—Anorexia—Tamoxifen—breast cancer	0.00226	0.00338	CcSEcCtD
Phendimetrazine—Diarrhoea—Idarubicin—breast cancer	0.00225	0.00336	CcSEcCtD
Phendimetrazine—Diarrhoea—Raloxifene—breast cancer	0.00225	0.00336	CcSEcCtD
Phendimetrazine—Dysuria—Paclitaxel—breast cancer	0.00225	0.00335	CcSEcCtD
Phendimetrazine—Vision blurred—Thiotepa—breast cancer	0.00224	0.00334	CcSEcCtD
Phendimetrazine—Pollakiuria—Paclitaxel—breast cancer	0.00222	0.00331	CcSEcCtD
Phendimetrazine—Anorexia—Melphalan—breast cancer	0.00222	0.00331	CcSEcCtD
Phendimetrazine—Tachycardia—Goserelin—breast cancer	0.00221	0.0033	CcSEcCtD
Phendimetrazine—Palpitations—Vinorelbine—breast cancer	0.0022	0.00328	CcSEcCtD
Phendimetrazine—Hyperhidrosis—Goserelin—breast cancer	0.00219	0.00327	CcSEcCtD
Phendimetrazine—Nausea—Ixabepilone—breast cancer	0.00219	0.00327	CcSEcCtD
Phendimetrazine—Flushing—Irinotecan—breast cancer	0.00219	0.00327	CcSEcCtD
Phendimetrazine—Agitation—Thiotepa—breast cancer	0.00218	0.00326	CcSEcCtD
Phendimetrazine—Dizziness—Raloxifene—breast cancer	0.00218	0.00325	CcSEcCtD
Phendimetrazine—Headache—Anastrozole—breast cancer	0.00217	0.00324	CcSEcCtD
Phendimetrazine—Headache—Letrozole—breast cancer	0.00217	0.00324	CcSEcCtD
Phendimetrazine—Anorexia—Goserelin—breast cancer	0.00216	0.00323	CcSEcCtD
Phendimetrazine—Abdominal pain upper—Docetaxel—breast cancer	0.00215	0.00321	CcSEcCtD
Phendimetrazine—Insomnia—Tamoxifen—breast cancer	0.00215	0.00321	CcSEcCtD
Phendimetrazine—Decreased appetite—Vinblastine—breast cancer	0.00212	0.00317	CcSEcCtD
Phendimetrazine—Abdominal pain—Chlorambucil—breast cancer	0.00211	0.00315	CcSEcCtD
Phendimetrazine—Constipation—Vinblastine—breast cancer	0.00209	0.00312	CcSEcCtD
Phendimetrazine—Abdominal pain upper—Capecitabine—breast cancer	0.00208	0.00311	CcSEcCtD
Phendimetrazine—Decreased appetite—Tamoxifen—breast cancer	0.00206	0.00308	CcSEcCtD
Phendimetrazine—Headache—Idarubicin—breast cancer	0.00206	0.00308	CcSEcCtD
Phendimetrazine—Headache—Raloxifene—breast cancer	0.00206	0.00308	CcSEcCtD
Phendimetrazine—Nausea—Letrozole—breast cancer	0.00206	0.00308	CcSEcCtD
Phendimetrazine—Nausea—Anastrozole—breast cancer	0.00206	0.00308	CcSEcCtD
Phendimetrazine—Insomnia—Goserelin—breast cancer	0.00205	0.00306	CcSEcCtD
Phendimetrazine—Constipation—Tamoxifen—breast cancer	0.00203	0.00303	CcSEcCtD
Phendimetrazine—Decreased appetite—Melphalan—breast cancer	0.00202	0.00302	CcSEcCtD
Phendimetrazine—Tachycardia—Vinorelbine—breast cancer	0.00198	0.00296	CcSEcCtD
Phendimetrazine—Decreased appetite—Goserelin—breast cancer	0.00197	0.00294	CcSEcCtD
Phendimetrazine—Nausea—Idarubicin—breast cancer	0.00196	0.00292	CcSEcCtD
Phendimetrazine—Nausea—Raloxifene—breast cancer	0.00196	0.00292	CcSEcCtD
Phendimetrazine—Constipation—Goserelin—breast cancer	0.00194	0.0029	CcSEcCtD
Phendimetrazine—Anorexia—Vinorelbine—breast cancer	0.00194	0.00289	CcSEcCtD
Phendimetrazine—Vision blurred—Mitoxantrone—breast cancer	0.00193	0.00289	CcSEcCtD
Phendimetrazine—Abdominal pain—Vinblastine—breast cancer	0.00193	0.00288	CcSEcCtD
Phendimetrazine—Tachycardia—Thiotepa—breast cancer	0.00189	0.00283	CcSEcCtD
Phendimetrazine—Abdominal pain—Tamoxifen—breast cancer	0.00188	0.0028	CcSEcCtD
Phendimetrazine—Vision blurred—Fluorouracil—breast cancer	0.00185	0.00277	CcSEcCtD
Phendimetrazine—Anorexia—Thiotepa—breast cancer	0.00185	0.00276	CcSEcCtD
Phendimetrazine—Dysuria—Capecitabine—breast cancer	0.00184	0.00275	CcSEcCtD
Phendimetrazine—Diarrhoea—Chlorambucil—breast cancer	0.00182	0.00272	CcSEcCtD
Phendimetrazine—Abdominal pain—Goserelin—breast cancer	0.00179	0.00268	CcSEcCtD
Phendimetrazine—Flushing—Paclitaxel—breast cancer	0.00178	0.00266	CcSEcCtD
Phendimetrazine—Decreased appetite—Vinorelbine—breast cancer	0.00177	0.00264	CcSEcCtD
Phendimetrazine—Constipation—Vinorelbine—breast cancer	0.00174	0.00259	CcSEcCtD
Phendimetrazine—Decreased appetite—Thiotepa—breast cancer	0.00169	0.00252	CcSEcCtD
Phendimetrazine—Diarrhoea—Vinblastine—breast cancer	0.00167	0.0025	CcSEcCtD
Phendimetrazine—Constipation—Thiotepa—breast cancer	0.00166	0.00248	CcSEcCtD
Phendimetrazine—Tachycardia—Mitoxantrone—breast cancer	0.00163	0.00244	CcSEcCtD
Phendimetrazine—Diarrhoea—Tamoxifen—breast cancer	0.00162	0.00243	CcSEcCtD
Phendimetrazine—Hyperhidrosis—Mitoxantrone—breast cancer	0.00162	0.00242	CcSEcCtD
Phendimetrazine—Hyperhidrosis—Irinotecan—breast cancer	0.00162	0.00242	CcSEcCtD
Phendimetrazine—Dizziness—Vinblastine—breast cancer	0.00162	0.00241	CcSEcCtD
Phendimetrazine—Abdominal pain—Vinorelbine—breast cancer	0.00161	0.0024	CcSEcCtD
Phendimetrazine—Anorexia—Irinotecan—breast cancer	0.0016	0.00238	CcSEcCtD
Phendimetrazine—Anorexia—Mitoxantrone—breast cancer	0.0016	0.00238	CcSEcCtD
Phendimetrazine—Diarrhoea—Melphalan—breast cancer	0.00159	0.00237	CcSEcCtD
Phendimetrazine—Nausea—Chlorambucil—breast cancer	0.00158	0.00237	CcSEcCtD
Phendimetrazine—Vision blurred—Paclitaxel—breast cancer	0.00158	0.00236	CcSEcCtD
Phendimetrazine—Hyperhidrosis—Gemcitabine—breast cancer	0.00158	0.00235	CcSEcCtD
Phendimetrazine—Dizziness—Tamoxifen—breast cancer	0.00157	0.00234	CcSEcCtD
Phendimetrazine—Tremor—Paclitaxel—breast cancer	0.00157	0.00234	CcSEcCtD
Phendimetrazine—Tachycardia—Fluorouracil—breast cancer	0.00157	0.00234	CcSEcCtD
Phendimetrazine—Anorexia—Gemcitabine—breast cancer	0.00156	0.00232	CcSEcCtD
Phendimetrazine—Diarrhoea—Goserelin—breast cancer	0.00155	0.00232	CcSEcCtD
Phendimetrazine—Agitation—Paclitaxel—breast cancer	0.00154	0.0023	CcSEcCtD
Phendimetrazine—Abdominal pain—Thiotepa—breast cancer	0.00153	0.00229	CcSEcCtD
Phendimetrazine—Headache—Vinblastine—breast cancer	0.00153	0.00229	CcSEcCtD
Phendimetrazine—Anorexia—Fluorouracil—breast cancer	0.00153	0.00228	CcSEcCtD
Phendimetrazine—Insomnia—Irinotecan—breast cancer	0.00151	0.00226	CcSEcCtD
Phendimetrazine—Flushing—Docetaxel—breast cancer	0.00151	0.00226	CcSEcCtD
Phendimetrazine—Dizziness—Goserelin—breast cancer	0.0015	0.00224	CcSEcCtD
Phendimetrazine—Headache—Tamoxifen—breast cancer	0.00149	0.00222	CcSEcCtD
Phendimetrazine—Palpitations—Paclitaxel—breast cancer	0.00148	0.00221	CcSEcCtD
Phendimetrazine—Insomnia—Gemcitabine—breast cancer	0.00148	0.0022	CcSEcCtD
Phendimetrazine—Flushing—Capecitabine—breast cancer	0.00146	0.00219	CcSEcCtD
Phendimetrazine—Decreased appetite—Irinotecan—breast cancer	0.00146	0.00217	CcSEcCtD
Phendimetrazine—Decreased appetite—Mitoxantrone—breast cancer	0.00146	0.00217	CcSEcCtD
Phendimetrazine—Nausea—Vinblastine—breast cancer	0.00145	0.00217	CcSEcCtD
Phendimetrazine—Abdominal pain upper—Epirubicin—breast cancer	0.00145	0.00217	CcSEcCtD
Phendimetrazine—Insomnia—Fluorouracil—breast cancer	0.00145	0.00217	CcSEcCtD
Phendimetrazine—Constipation—Irinotecan—breast cancer	0.00143	0.00214	CcSEcCtD
Phendimetrazine—Constipation—Mitoxantrone—breast cancer	0.00143	0.00214	CcSEcCtD
Phendimetrazine—Headache—Goserelin—breast cancer	0.00142	0.00212	CcSEcCtD
Phendimetrazine—Decreased appetite—Gemcitabine—breast cancer	0.00142	0.00212	CcSEcCtD
Phendimetrazine—Nausea—Tamoxifen—breast cancer	0.00141	0.00211	CcSEcCtD
Phendimetrazine—Constipation—Gemcitabine—breast cancer	0.0014	0.00208	CcSEcCtD
Phendimetrazine—Decreased appetite—Fluorouracil—breast cancer	0.00139	0.00208	CcSEcCtD
Phendimetrazine—Diarrhoea—Vinorelbine—breast cancer	0.00139	0.00207	CcSEcCtD
Phendimetrazine—Nausea—Melphalan—breast cancer	0.00138	0.00206	CcSEcCtD
Phendimetrazine—Dysuria—Methotrexate—breast cancer	0.00137	0.00205	CcSEcCtD
Phendimetrazine—Nausea—Goserelin—breast cancer	0.00135	0.00201	CcSEcCtD
Phendimetrazine—Dizziness—Vinorelbine—breast cancer	0.00134	0.00201	CcSEcCtD
Phendimetrazine—Abdominal pain upper—Doxorubicin—breast cancer	0.00134	0.002	CcSEcCtD
Phendimetrazine—Tachycardia—Paclitaxel—breast cancer	0.00133	0.00199	CcSEcCtD
Phendimetrazine—Diarrhoea—Thiotepa—breast cancer	0.00133	0.00198	CcSEcCtD
Phendimetrazine—Abdominal pain—Mitoxantrone—breast cancer	0.00132	0.00198	CcSEcCtD
Phendimetrazine—Abdominal pain—Irinotecan—breast cancer	0.00132	0.00198	CcSEcCtD
Phendimetrazine—Hyperhidrosis—Paclitaxel—breast cancer	0.00132	0.00197	CcSEcCtD
Phendimetrazine—Anorexia—Paclitaxel—breast cancer	0.0013	0.00194	CcSEcCtD
Phendimetrazine—Vision blurred—Capecitabine—breast cancer	0.00129	0.00193	CcSEcCtD
Phendimetrazine—Tremor—Capecitabine—breast cancer	0.00129	0.00192	CcSEcCtD
Phendimetrazine—Dysuria—Epirubicin—breast cancer	0.00128	0.00192	CcSEcCtD
Phendimetrazine—Dizziness—Thiotepa—breast cancer	0.00128	0.00191	CcSEcCtD
Phendimetrazine—Headache—Vinorelbine—breast cancer	0.00127	0.0019	CcSEcCtD
Phendimetrazine—Pollakiuria—Epirubicin—breast cancer	0.00127	0.00189	CcSEcCtD
Phendimetrazine—Sweating—Methotrexate—breast cancer	0.00125	0.00187	CcSEcCtD
Phendimetrazine—Palpitations—Docetaxel—breast cancer	0.00125	0.00187	CcSEcCtD
Phendimetrazine—Insomnia—Paclitaxel—breast cancer	0.00124	0.00184	CcSEcCtD
Phendimetrazine—Headache—Thiotepa—breast cancer	0.00122	0.00181	CcSEcCtD
Phendimetrazine—Palpitations—Capecitabine—breast cancer	0.00121	0.00181	CcSEcCtD
Phendimetrazine—Nausea—Vinorelbine—breast cancer	0.00121	0.0018	CcSEcCtD
Phendimetrazine—Dysuria—Doxorubicin—breast cancer	0.00119	0.00177	CcSEcCtD
Phendimetrazine—Decreased appetite—Paclitaxel—breast cancer	0.00119	0.00177	CcSEcCtD
Phendimetrazine—Sweating—Epirubicin—breast cancer	0.00117	0.00175	CcSEcCtD
Phendimetrazine—Pollakiuria—Doxorubicin—breast cancer	0.00117	0.00175	CcSEcCtD
Phendimetrazine—Constipation—Paclitaxel—breast cancer	0.00117	0.00174	CcSEcCtD
Phendimetrazine—Nausea—Thiotepa—breast cancer	0.00115	0.00172	CcSEcCtD
Phendimetrazine—Diarrhoea—Mitoxantrone—breast cancer	0.00115	0.00171	CcSEcCtD
Phendimetrazine—Diarrhoea—Irinotecan—breast cancer	0.00115	0.00171	CcSEcCtD
Phendimetrazine—Tachycardia—Docetaxel—breast cancer	0.00113	0.00169	CcSEcCtD
Phendimetrazine—Diarrhoea—Gemcitabine—breast cancer	0.00112	0.00167	CcSEcCtD
Phendimetrazine—Dizziness—Irinotecan—breast cancer	0.00111	0.00165	CcSEcCtD
Phendimetrazine—Anorexia—Docetaxel—breast cancer	0.0011	0.00165	CcSEcCtD
Phendimetrazine—Diarrhoea—Fluorouracil—breast cancer	0.0011	0.00164	CcSEcCtD
Phendimetrazine—Tachycardia—Capecitabine—breast cancer	0.00109	0.00163	CcSEcCtD
Phendimetrazine—Sweating—Doxorubicin—breast cancer	0.00109	0.00162	CcSEcCtD
Phendimetrazine—Hyperhidrosis—Capecitabine—breast cancer	0.00108	0.00162	CcSEcCtD
Phendimetrazine—Abdominal pain—Paclitaxel—breast cancer	0.00108	0.00161	CcSEcCtD
Phendimetrazine—Anorexia—Capecitabine—breast cancer	0.00107	0.0016	CcSEcCtD
Phendimetrazine—Dizziness—Fluorouracil—breast cancer	0.00106	0.00158	CcSEcCtD
Phendimetrazine—Headache—Mitoxantrone—breast cancer	0.00105	0.00157	CcSEcCtD
Phendimetrazine—Headache—Irinotecan—breast cancer	0.00105	0.00157	CcSEcCtD
Phendimetrazine—Insomnia—Docetaxel—breast cancer	0.00105	0.00156	CcSEcCtD
Phendimetrazine—Headache—Gemcitabine—breast cancer	0.00102	0.00153	CcSEcCtD
Phendimetrazine—Flushing—Epirubicin—breast cancer	0.00102	0.00152	CcSEcCtD
Phendimetrazine—Insomnia—Capecitabine—breast cancer	0.00101	0.00151	CcSEcCtD
Phendimetrazine—Decreased appetite—Docetaxel—breast cancer	0.00101	0.0015	CcSEcCtD
Phendimetrazine—Headache—Fluorouracil—breast cancer	0.00101	0.0015	CcSEcCtD
Phendimetrazine—Nausea—Mitoxantrone—breast cancer	0.000995	0.00149	CcSEcCtD
Phendimetrazine—Nausea—Irinotecan—breast cancer	0.000995	0.00149	CcSEcCtD
Phendimetrazine—Constipation—Docetaxel—breast cancer	0.00099	0.00148	CcSEcCtD
Phendimetrazine—Decreased appetite—Capecitabine—breast cancer	0.000975	0.00145	CcSEcCtD
Phendimetrazine—Nausea—Gemcitabine—breast cancer	0.000969	0.00145	CcSEcCtD
Phendimetrazine—Vision blurred—Methotrexate—breast cancer	0.000964	0.00144	CcSEcCtD
Phendimetrazine—Constipation—Capecitabine—breast cancer	0.000959	0.00143	CcSEcCtD
Phendimetrazine—Nausea—Fluorouracil—breast cancer	0.000953	0.00142	CcSEcCtD
Phendimetrazine—Flushing—Doxorubicin—breast cancer	0.000944	0.00141	CcSEcCtD
Phendimetrazine—Diarrhoea—Paclitaxel—breast cancer	0.000935	0.0014	CcSEcCtD
Phendimetrazine—Abdominal pain—Docetaxel—breast cancer	0.000915	0.00137	CcSEcCtD
Phendimetrazine—Dizziness—Paclitaxel—breast cancer	0.000903	0.00135	CcSEcCtD
Phendimetrazine—Vision blurred—Epirubicin—breast cancer	0.000902	0.00135	CcSEcCtD
Phendimetrazine—Abdominal pain—Capecitabine—breast cancer	0.000886	0.00132	CcSEcCtD
Phendimetrazine—Agitation—Epirubicin—breast cancer	0.000879	0.00131	CcSEcCtD
Phendimetrazine—Headache—Paclitaxel—breast cancer	0.000856	0.00128	CcSEcCtD
Phendimetrazine—Palpitations—Epirubicin—breast cancer	0.000846	0.00126	CcSEcCtD
Phendimetrazine—Vision blurred—Doxorubicin—breast cancer	0.000834	0.00125	CcSEcCtD
Phendimetrazine—Agitation—Doxorubicin—breast cancer	0.000814	0.00121	CcSEcCtD
Phendimetrazine—Nausea—Paclitaxel—breast cancer	0.000811	0.00121	CcSEcCtD
Phendimetrazine—Hyperhidrosis—Methotrexate—breast cancer	0.000807	0.0012	CcSEcCtD
Phendimetrazine—Anorexia—Methotrexate—breast cancer	0.000795	0.00119	CcSEcCtD
Phendimetrazine—Diarrhoea—Docetaxel—breast cancer	0.000792	0.00118	CcSEcCtD
Phendimetrazine—Palpitations—Doxorubicin—breast cancer	0.000782	0.00117	CcSEcCtD
Phendimetrazine—Diarrhoea—Capecitabine—breast cancer	0.000767	0.00115	CcSEcCtD
Phendimetrazine—Dizziness—Docetaxel—breast cancer	0.000766	0.00114	CcSEcCtD
Phendimetrazine—Tachycardia—Epirubicin—breast cancer	0.000762	0.00114	CcSEcCtD
Phendimetrazine—Hyperhidrosis—Epirubicin—breast cancer	0.000755	0.00113	CcSEcCtD
Phendimetrazine—Insomnia—Methotrexate—breast cancer	0.000755	0.00113	CcSEcCtD
Phendimetrazine—Anorexia—Epirubicin—breast cancer	0.000744	0.00111	CcSEcCtD
Phendimetrazine—Dizziness—Capecitabine—breast cancer	0.000741	0.00111	CcSEcCtD
Phendimetrazine—Decreased appetite—Methotrexate—breast cancer	0.000725	0.00108	CcSEcCtD
Phendimetrazine—Headache—Docetaxel—breast cancer	0.000725	0.00108	CcSEcCtD
Phendimetrazine—Insomnia—Epirubicin—breast cancer	0.000706	0.00105	CcSEcCtD
Phendimetrazine—Tachycardia—Doxorubicin—breast cancer	0.000705	0.00105	CcSEcCtD
Phendimetrazine—Headache—Capecitabine—breast cancer	0.000702	0.00105	CcSEcCtD
Phendimetrazine—Hyperhidrosis—Doxorubicin—breast cancer	0.000699	0.00104	CcSEcCtD
Phendimetrazine—Anorexia—Doxorubicin—breast cancer	0.000689	0.00103	CcSEcCtD
Phendimetrazine—Nausea—Docetaxel—breast cancer	0.000688	0.00103	CcSEcCtD
Phendimetrazine—Decreased appetite—Epirubicin—breast cancer	0.000679	0.00101	CcSEcCtD
Phendimetrazine—Constipation—Epirubicin—breast cancer	0.000668	0.000997	CcSEcCtD
Phendimetrazine—Nausea—Capecitabine—breast cancer	0.000666	0.000994	CcSEcCtD
Phendimetrazine—Abdominal pain—Methotrexate—breast cancer	0.00066	0.000985	CcSEcCtD
Phendimetrazine—Insomnia—Doxorubicin—breast cancer	0.000654	0.000976	CcSEcCtD
Phendimetrazine—Decreased appetite—Doxorubicin—breast cancer	0.000628	0.000938	CcSEcCtD
Phendimetrazine—Constipation—Doxorubicin—breast cancer	0.000618	0.000923	CcSEcCtD
Phendimetrazine—Abdominal pain—Epirubicin—breast cancer	0.000617	0.000922	CcSEcCtD
Phendimetrazine—Abdominal pain—Doxorubicin—breast cancer	0.000571	0.000853	CcSEcCtD
Phendimetrazine—Diarrhoea—Methotrexate—breast cancer	0.000571	0.000852	CcSEcCtD
Phendimetrazine—Dizziness—Methotrexate—breast cancer	0.000552	0.000824	CcSEcCtD
Phendimetrazine—Diarrhoea—Epirubicin—breast cancer	0.000534	0.000798	CcSEcCtD
Phendimetrazine—Headache—Methotrexate—breast cancer	0.000523	0.000781	CcSEcCtD
Phendimetrazine—Dizziness—Epirubicin—breast cancer	0.000516	0.000771	CcSEcCtD
Phendimetrazine—Nausea—Methotrexate—breast cancer	0.000496	0.00074	CcSEcCtD
Phendimetrazine—Diarrhoea—Doxorubicin—breast cancer	0.000494	0.000738	CcSEcCtD
Phendimetrazine—Headache—Epirubicin—breast cancer	0.000489	0.00073	CcSEcCtD
Phendimetrazine—Dizziness—Doxorubicin—breast cancer	0.000478	0.000713	CcSEcCtD
Phendimetrazine—Nausea—Epirubicin—breast cancer	0.000464	0.000693	CcSEcCtD
Phendimetrazine—Headache—Doxorubicin—breast cancer	0.000453	0.000676	CcSEcCtD
Phendimetrazine—Nausea—Doxorubicin—breast cancer	0.000429	0.000641	CcSEcCtD
Phendimetrazine—ADRA1A—GPCR ligand binding—CXCL8—breast cancer	8.82e-05	0.000267	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—MMP3—breast cancer	8.8e-05	0.000267	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—GZMB—breast cancer	8.8e-05	0.000266	CbGpPWpGaD
Phendimetrazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—breast cancer	8.79e-05	0.000266	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—DKK1—breast cancer	8.61e-05	0.000261	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—VEGFC—breast cancer	8.55e-05	0.000259	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—CXCL2—breast cancer	8.54e-05	0.000259	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—AGTR2—breast cancer	8.54e-05	0.000259	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—BMP2—breast cancer	8.45e-05	0.000256	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—PTHLH—breast cancer	8.45e-05	0.000256	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—JAG2—breast cancer	8.42e-05	0.000255	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—WNT1—breast cancer	8.3e-05	0.000251	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—PLA2G4A—breast cancer	8.28e-05	0.000251	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—CSF2—breast cancer	8.18e-05	0.000248	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—EDNRB—breast cancer	8.18e-05	0.000248	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—PGR—breast cancer	8.1e-05	0.000245	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—THBS1—breast cancer	8.06e-05	0.000244	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—NOTCH4—breast cancer	7.86e-05	0.000238	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—GZMB—breast cancer	7.82e-05	0.000237	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—FLT1—breast cancer	7.69e-05	0.000233	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—FGF3—breast cancer	7.66e-05	0.000232	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—SQSTM1—breast cancer	7.66e-05	0.000232	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—PIK3CG—breast cancer	7.62e-05	0.000231	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—CXCL2—breast cancer	7.59e-05	0.00023	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—AGTR2—breast cancer	7.59e-05	0.00023	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—JAG1—breast cancer	7.56e-05	0.000229	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—NOTCH3—breast cancer	7.53e-05	0.000228	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—PARP1—breast cancer	7.53e-05	0.000228	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—BMP2—breast cancer	7.5e-05	0.000227	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PTHLH—breast cancer	7.5e-05	0.000227	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—CALCA—breast cancer	7.44e-05	0.000225	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—RPS6—breast cancer	7.35e-05	0.000223	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—FGF4—breast cancer	7.29e-05	0.000221	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—EDNRB—breast cancer	7.27e-05	0.00022	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—CXCR4—breast cancer	7.26e-05	0.00022	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—CXCL12—breast cancer	7.26e-05	0.00022	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PGR—breast cancer	7.19e-05	0.000218	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—THBS1—breast cancer	7.16e-05	0.000217	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—PAK1—breast cancer	7.13e-05	0.000216	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—TCF7L2—breast cancer	7e-05	0.000212	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—AKT2—breast cancer	6.97e-05	0.000211	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—PIK3CG—breast cancer	6.92e-05	0.00021	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—FLT1—breast cancer	6.83e-05	0.000207	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—FGF3—breast cancer	6.8e-05	0.000206	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—SQSTM1—breast cancer	6.8e-05	0.000206	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—PIK3CG—breast cancer	6.77e-05	0.000205	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—HSP90AA1—breast cancer	6.75e-05	0.000205	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—NOTCH2—breast cancer	6.75e-05	0.000205	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—JAG1—breast cancer	6.72e-05	0.000203	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—PIK3CD—breast cancer	6.7e-05	0.000203	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—NOTCH3—breast cancer	6.69e-05	0.000203	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PARP1—breast cancer	6.69e-05	0.000203	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—CALCA—breast cancer	6.61e-05	0.0002	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—PRL—breast cancer	6.57e-05	0.000199	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—AGTR1—breast cancer	6.57e-05	0.000199	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—RPS6—breast cancer	6.53e-05	0.000198	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—FGF4—breast cancer	6.48e-05	0.000196	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—STK11—breast cancer	6.47e-05	0.000196	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—ADAM10—breast cancer	6.47e-05	0.000196	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—CXCL12—breast cancer	6.45e-05	0.000195	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—CXCR4—breast cancer	6.45e-05	0.000195	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—PLG—breast cancer	6.4e-05	0.000194	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PAK1—breast cancer	6.33e-05	0.000192	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—AKT2—breast cancer	6.33e-05	0.000192	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—FGF10—breast cancer	6.3e-05	0.000191	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—TCF7L2—breast cancer	6.22e-05	0.000188	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—AKT2—breast cancer	6.19e-05	0.000188	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—PIK3CG—breast cancer	6.15e-05	0.000186	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—PIK3CD—breast cancer	6.08e-05	0.000184	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—PDGFA—breast cancer	6.08e-05	0.000184	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—HSP90AA1—breast cancer	6e-05	0.000182	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—NOTCH2—breast cancer	6e-05	0.000182	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—TGFBR2—breast cancer	5.99e-05	0.000181	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—PIK3CD—breast cancer	5.95e-05	0.00018	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—ITPR1—breast cancer	5.89e-05	0.000179	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—ERBB4—breast cancer	5.85e-05	0.000177	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—STAT5A—breast cancer	5.85e-05	0.000177	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—MMP3—breast cancer	5.85e-05	0.000177	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—PIK3CB—breast cancer	5.84e-05	0.000177	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PRL—breast cancer	5.83e-05	0.000177	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—AGTR1—breast cancer	5.83e-05	0.000177	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—STK11—breast cancer	5.75e-05	0.000174	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—ADAM10—breast cancer	5.75e-05	0.000174	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PLG—breast cancer	5.69e-05	0.000172	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—SMAD4—breast cancer	5.67e-05	0.000172	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—IGF1R—breast cancer	5.64e-05	0.000171	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—AKT2—breast cancer	5.62e-05	0.00017	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—CXCL8—breast cancer	5.61e-05	0.00017	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—FGF10—breast cancer	5.59e-05	0.000169	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—HES1—breast cancer	5.54e-05	0.000168	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—NCOR1—breast cancer	5.5e-05	0.000167	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—PLA2G4A—breast cancer	5.5e-05	0.000167	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—CSF2—breast cancer	5.44e-05	0.000165	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—FGF1—breast cancer	5.44e-05	0.000165	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—RAF1—breast cancer	5.43e-05	0.000164	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—NRG1—breast cancer	5.4e-05	0.000164	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—PIK3CD—breast cancer	5.4e-05	0.000164	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PDGFA—breast cancer	5.4e-05	0.000163	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—H2AFX—breast cancer	5.36e-05	0.000162	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—IL2—breast cancer	5.36e-05	0.000162	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—E2F1—breast cancer	5.33e-05	0.000161	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—TGFBR2—breast cancer	5.32e-05	0.000161	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—PIK3CB—breast cancer	5.3e-05	0.000161	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—ITPR1—breast cancer	5.24e-05	0.000159	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—MMP3—breast cancer	5.2e-05	0.000157	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—ERBB4—breast cancer	5.2e-05	0.000157	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—STAT5A—breast cancer	5.2e-05	0.000157	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—PIK3CB—breast cancer	5.19e-05	0.000157	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—SPP1—breast cancer	5.12e-05	0.000155	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—CXCL8—breast cancer	5.1e-05	0.000154	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—ERBB3—breast cancer	5.06e-05	0.000153	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—FGFR2—breast cancer	5.05e-05	0.000153	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—SMAD4—breast cancer	5.04e-05	0.000153	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—IGF1R—breast cancer	5.01e-05	0.000152	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—CXCL8—breast cancer	4.98e-05	0.000151	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—HES1—breast cancer	4.92e-05	0.000149	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PLA2G4A—breast cancer	4.89e-05	0.000148	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—NCOR1—breast cancer	4.89e-05	0.000148	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—IL2—breast cancer	4.87e-05	0.000147	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—TERT—breast cancer	4.85e-05	0.000147	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—FGF1—breast cancer	4.83e-05	0.000146	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—CSF2—breast cancer	4.83e-05	0.000146	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—RAF1—breast cancer	4.82e-05	0.000146	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—NRG1—breast cancer	4.8e-05	0.000145	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—H2AFX—breast cancer	4.77e-05	0.000144	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—IL2—breast cancer	4.76e-05	0.000144	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—E2F1—breast cancer	4.73e-05	0.000143	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—FGFR1—breast cancer	4.71e-05	0.000143	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—PIK3CB—breast cancer	4.71e-05	0.000143	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—HIF1A—breast cancer	4.64e-05	0.000141	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—SPP1—breast cancer	4.55e-05	0.000138	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—LEP—breast cancer	4.53e-05	0.000137	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—CXCL8—breast cancer	4.53e-05	0.000137	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—ERBB3—breast cancer	4.5e-05	0.000136	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—FGFR2—breast cancer	4.49e-05	0.000136	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—CAV1—breast cancer	4.49e-05	0.000136	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—KDR—breast cancer	4.44e-05	0.000134	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—IL2—breast cancer	4.33e-05	0.000131	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—ESR1—breast cancer	4.32e-05	0.000131	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—TERT—breast cancer	4.31e-05	0.000131	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—FN1—breast cancer	4.27e-05	0.000129	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—NFKBIA—breast cancer	4.22e-05	0.000128	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—FGFR1—breast cancer	4.18e-05	0.000127	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—NOTCH1—breast cancer	4.18e-05	0.000127	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—HIF1A—breast cancer	4.12e-05	0.000125	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—PIK3CG—breast cancer	4.09e-05	0.000124	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—KIT—breast cancer	4.09e-05	0.000124	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—APC—breast cancer	4.09e-05	0.000124	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—EGF—breast cancer	4.04e-05	0.000122	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—LEP—breast cancer	4.02e-05	0.000122	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—CAV1—breast cancer	3.99e-05	0.000121	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—KDR—breast cancer	3.94e-05	0.000119	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—MAPK3—breast cancer	3.91e-05	0.000119	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—BRAF—breast cancer	3.84e-05	0.000116	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—ESR1—breast cancer	3.84e-05	0.000116	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—FN1—breast cancer	3.79e-05	0.000115	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—NFKBIA—breast cancer	3.75e-05	0.000114	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—IGF1—breast cancer	3.74e-05	0.000113	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—AKT2—breast cancer	3.74e-05	0.000113	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—EGFR—breast cancer	3.72e-05	0.000113	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—NOTCH1—breast cancer	3.71e-05	0.000112	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—APC—breast cancer	3.63e-05	0.00011	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—KIT—breast cancer	3.63e-05	0.00011	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PIK3CG—breast cancer	3.63e-05	0.00011	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—PIK3CD—breast cancer	3.59e-05	0.000109	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—EGF—breast cancer	3.59e-05	0.000109	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—PIK3CA—breast cancer	3.56e-05	0.000108	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—SERPINE1—breast cancer	3.55e-05	0.000108	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—KRAS—breast cancer	3.52e-05	0.000107	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—MAPK3—breast cancer	3.48e-05	0.000105	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—BRAF—breast cancer	3.41e-05	0.000103	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—NOS3—breast cancer	3.39e-05	0.000103	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—IGF1—breast cancer	3.32e-05	0.000101	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—AKT2—breast cancer	3.32e-05	0.000101	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—EGFR—breast cancer	3.31e-05	0.0001	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—PIK3CA—breast cancer	3.23e-05	9.79e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—MDM2—breast cancer	3.22e-05	9.75e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—RAF1—breast cancer	3.21e-05	9.72e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—RELA—breast cancer	3.19e-05	9.67e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PIK3CD—breast cancer	3.19e-05	9.67e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—ERBB2—breast cancer	3.17e-05	9.61e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—PIK3CA—breast cancer	3.16e-05	9.57e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—SERPINE1—breast cancer	3.16e-05	9.56e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—MTOR—breast cancer	3.13e-05	9.49e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—PIK3CB—breast cancer	3.13e-05	9.49e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—KRAS—breast cancer	3.12e-05	9.46e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—NOS3—breast cancer	3.01e-05	9.13e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—CXCL8—breast cancer	3.01e-05	9.12e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—HRAS—breast cancer	2.99e-05	9.06e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—CDKN1B—breast cancer	2.94e-05	8.9e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—AKT1—breast cancer	2.91e-05	8.81e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—CASP3—breast cancer	2.88e-05	8.72e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—IL2—breast cancer	2.88e-05	8.71e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—PIK3CA—breast cancer	2.87e-05	8.69e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—IL6—breast cancer	2.86e-05	8.67e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—MDM2—breast cancer	2.86e-05	8.66e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—RAF1—breast cancer	2.85e-05	8.63e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—RELA—breast cancer	2.84e-05	8.59e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—ERBB2—breast cancer	2.82e-05	8.54e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—CCND1—breast cancer	2.8e-05	8.49e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—JUN—breast cancer	2.8e-05	8.47e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PIK3CB—breast cancer	2.78e-05	8.43e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—MTOR—breast cancer	2.78e-05	8.43e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—CTNNB1—breast cancer	2.78e-05	8.41e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—MMP9—breast cancer	2.72e-05	8.24e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—CDKN1A—breast cancer	2.71e-05	8.22e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—PTEN—breast cancer	2.71e-05	8.2e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—CXCL8—breast cancer	2.67e-05	8.1e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—HRAS—breast cancer	2.66e-05	8.04e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—MAPK8—breast cancer	2.65e-05	8.02e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—AKT1—breast cancer	2.64e-05	8e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—CDKN1B—breast cancer	2.61e-05	7.91e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—AKT1—breast cancer	2.58e-05	7.82e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—CASP3—breast cancer	2.56e-05	7.75e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—IL2—breast cancer	2.55e-05	7.74e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—IL6—breast cancer	2.54e-05	7.7e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—SRC—breast cancer	2.51e-05	7.6e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—CCND1—breast cancer	2.49e-05	7.54e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—JUN—breast cancer	2.49e-05	7.53e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—CTNNB1—breast cancer	2.47e-05	7.47e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—VEGFA—breast cancer	2.44e-05	7.4e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—STAT3—breast cancer	2.42e-05	7.33e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—MMP9—breast cancer	2.42e-05	7.32e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—CDKN1A—breast cancer	2.41e-05	7.3e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PTEN—breast cancer	2.4e-05	7.28e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—MAPK8—breast cancer	2.35e-05	7.12e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—AKT1—breast cancer	2.35e-05	7.1e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—MAPK3—breast cancer	2.31e-05	7e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—MYC—breast cancer	2.25e-05	6.81e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—TGFB1—breast cancer	2.24e-05	6.79e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—SRC—breast cancer	2.23e-05	6.75e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—EGFR—breast cancer	2.2e-05	6.66e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—VEGFA—breast cancer	2.17e-05	6.58e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—STAT3—breast cancer	2.15e-05	6.51e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—KRAS—breast cancer	2.08e-05	6.29e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—MAPK3—breast cancer	2.05e-05	6.22e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—MYC—breast cancer	2e-05	6.05e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—TGFB1—breast cancer	1.99e-05	6.04e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—EGFR—breast cancer	1.95e-05	5.92e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—PIK3CA—breast cancer	1.91e-05	5.78e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—TP53—breast cancer	1.85e-05	5.59e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—KRAS—breast cancer	1.85e-05	5.59e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—HRAS—breast cancer	1.77e-05	5.35e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PIK3CA—breast cancer	1.7e-05	5.14e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—IL6—breast cancer	1.69e-05	5.12e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—TP53—breast cancer	1.64e-05	4.97e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—HRAS—breast cancer	1.57e-05	4.75e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—AKT1—breast cancer	1.56e-05	4.72e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—IL6—breast cancer	1.5e-05	4.55e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—AKT1—breast cancer	1.39e-05	4.2e-05	CbGpPWpGaD
